Considering the shortage of Fluoxetine 10mg tablets, the Department of Health and Social Care (DHSC) has extended the serious shortage protocol (SSP) for the medicine to February 11, 2022.
Earlier the SSP for Fluoxetine 10mg tablets was set to expire on November 12.
Extension of the transition period will enable use of No Cheaper Stock Obtainable (NCSO) endorsement and use of EPS tokens to claim for supplies made in accordance with SSPs.
The NHS Business Services Authority (NHSBSA) has accepted that either the new ‘SSP’ or existing ‘NCSO’ endorsement for any SSP claims can be submitted using electronic prescriptions (EPS) tokens of FP10 paper prescriptions, during the period.
The Pharmaceutical Services Negotiating Committee (PSNC) has secured an extension to the transition period by three months until February 2022.
“From February 2022, all contractors must use the ‘SSP’ endorsement,” the negotiator said.